Bibliometric analysis of the top 100 most cited articles on the immunotherapy for glioblastoma
Source: Child's Nervous System
Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine
Source: Neurogenetics
PET imaging of the anticancer drug candidate [<sup>11</sup>C]trimebutine in a rat glioma model
Source: Nuclear Medicine and Biology
Neuron-like lineage differentiation induced by exogenous Neurexin-1 as a potential therapeutic strategy for glioma
Source: Cancer Letters
Can we utilise the circadian clock to target cancer stem cells?
Source: Cancer Letters
For Patient Families
To support patients and caregivers, Elsevier Health is making the latest research on these rare disorders available upon request at no cost.
Learn More
Note:
User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.
Cookies are used by this site. To decline or learn more, visit our cookie notice.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
